News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

e-Therapeutics plc - Interim Results for the Six Months Ended 31 July 2012


10/22/2012 9:21:45 AM

LONDON--(BUSINESS WIRE)--e-Therapeutics plc (AIM: ETX), the drug discovery and development company, today announces its interim results for the six months ended 31 July 2012.

Highlights

(*Events since the end of the period; **announced today)

Lead cancer drug ETS2101 enters clinic

• US phase I trial initiated in patients with brain cancer

• UK phase I trial begins in patients with solid tumours*

• First data expected Q4 2012; final results from brain cancer trial Q4 2013 and solid tumour trial Q1 2014**


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES